Search results for "dysfunction"

showing 10 items of 1129 documents

Chronic physical conditions, multimorbidity, and mild cognitive impairment in low- and middle-Income countries

2018

BACKGROUND/OBJECTIVES: Chronic physical conditions and multimorbidity may be modifiable risk factors for dementia. However, data from low- and middle-income countries (LMICs) are lacking. This study thus assessed the association of chronic physical conditions and multimorbidity with mild cognitive impairment (MCI) in LMICs. DESIGN: Nationally representative, cross-sectional, community-based. SETTING: Six countries which participated in the World Health Organization’s Study on Global Ageing and Adult Health. PARTICIPANTS: 32,715 adults aged ≥50 years [mean (SD) age 62.1 (15.6) years; 51.7% females]. MEASUREMENTS: The definition of MCI was based on the recommendations of the National Institut…

Malechronic physical conditionChronic physical conditions; Low- and middle-income countries; Mild cognitive impairment; Multimorbidity; Geriatrics and GerontologyGlobal HealthArticlePrevalenceHumansCognitive DysfunctionDeveloping CountriesPovertyAgedAged 80 and overLow- and middle-income countriesMild cognitive impairmentMultimorbidityMiddle Aged*low- and middle-income countries*chronic physical conditionsChronic physical conditionsCross-Sectional Studies*mild cognitive impairmentChronic DiseaseFemale*multimorbidityGeriatrics and GerontologyDisfunção Cognitiva
researchProduct

What physical performance measures predict incident cognitive decline among intact older adults? A 4.4 year follow up study

2016

Reductions in physical performance, cognitive impairment (CI) and decline (CD), are common in older age, but few prospective cohort studies have considered the relationship between these domains. In this study we investigated whether reduced physical performance and low handgrip/lower limbs strength, could predict a higher incidence of CI/CD during a 4-year follow-up among a cohort of elderly individuals. From 3099 older community-dwelling individuals initially enrolled in the Progetto Veneto Anziani (PRO.V.A.) study, 1249 participants without CI at the baseline were included (mean age 72.2 years, 59.5% females). Physical performance measures included the Short Physical Performance Battery …

Malecognitionmedicine.medical_specialtyAgingPoison controlWalkingNeuropsychological TestsBiochemistryNOPhysical performancePhysical performance Muscle strength Cognition03 medical and health sciences0302 clinical medicineCognitionEndocrinologyInjury preventionGeneticsMedicineHumansCognitive Dysfunction030212 general & internal medicineCognitive declineProspective cohort studyGeriatric AssessmentMolecular BiologyAgedAged 80 and overPsychiatric Status Rating ScalesHand Strengthbusiness.industryMuscle strengthIncidence (epidemiology)Confoundingphysical performanceCell BiologyPreferred walking speedLogistic ModelsItalyCohortPhysical therapyExercise Testmuscle strengthFemaleCognition; Muscle strength; Physical performance; Aging; Biochemistry; Cell Biology; Endocrinology; Genetics; Molecular Biologybusinesshuman activities030217 neurology & neurosurgeryFollow-Up Studies
researchProduct

Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions

2017

Comprehensive geriatric assessment (CGA) is a multidisciplinary diagnostic and treatment process that identifies medical, psychosocial, and functional capabilities of older adults to develop a coordinated plan to maximize overall health with aging. Specific criteria used by CGA programs to evaluate patients include age, medical comorbidities, psychosocial problems, previous or predicted high healthcare utilization, change in living situation, and specific geriatric conditions. However, no universal criteria have been agreed upon to readily identify patients who are likely to benefit from CGA. Evidence from randomized controlled trials and large systematic reviews and meta-analyses suggested…

Maleendocrine systemmedicine.medical_specialtyHistory 21st Centurylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialMultidisciplinary approachlawemergency medicineHealth careHumansMedicinecancerCognitive DysfunctionMusculoskeletal Diseases030212 general & internal medicineIntensive care medicineGeriatric AssessmentGeneral NursingHealth policyNursing (all)2901 Nursing (miscellaneous)Agedcognitive impairmentAged 80 and overGeriatricsgeriatricsFrailtybusiness.industrycancer; cognitive impairment; emergency medicine; Frailty; geriatrics; orthopedics; Nursing (all)2901 Nursing (miscellaneous); Medicine (all); Health PolicyMedicine (all)Health PolicyGeriatric assessmentGeneral MedicineHistory 20th CenturySystematic reviewFrailty cancer cognitive impairment emergency medicine geriatrics orthopedicsPhysical therapyorthopedicsFemaleHealth FacilitiesGeriatrics and GerontologybusinessPsychosocial030217 neurology & neurosurgery
researchProduct

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multi…

2020

Abstract Aims To investigate the efficacy and safety of early transition from hospital to ambulatory treatment in low-risk acute PE, using the oral factor Xa inhibitor rivaroxaban. Methods and results We conducted a prospective multicentre single-arm investigator initiated and academically sponsored management trial in patients with acute low-risk PE (EudraCT Identifier 2013-001657-28). Eligibility criteria included absence of (i) haemodynamic instability, (ii) right ventricular dysfunction or intracardiac thrombi, and (iii) serious comorbidities. Up to two nights of hospital stay were permitted. Rivaroxaban was given at the approved dose for PE for ≥3 months. The primary outcome was sympto…

Malehome treatmentpulmonary embolismrisk stratification030204 cardiovascular system & hematology0302 clinical medicineRivaroxabanRecurrenceRisk FactorsOutpatientsMedicineProspective StudiesRight ventricular dysfunctionEarly dischargeAged 80 and overeducation.field_of_studyHome treatmentriskinarviointiMiddle AgedEUROPEAN-SOCIETYPatient DischargeINPATIENT TREATMENT3. Good healthPulmonary embolismTreatment OutcomeHOSPITALIZATIONAmbulatoryright ventricular dysfunctionFemaleCardiology and Cardiovascular Medicinemedicine.drugAdultmedicine.medical_specialtyAdolescentmanagement trialpotilaan kotiuttaminenkotihoitoPopulationDrug Administration Schedule03 medical and health sciencesYoung AdultInternal medicineMANAGEMENTkliiniset kokeetHumansseurantaddc:610Home treatment; Management trial; Pulmonary embolism; Right ventricular dysfunction; Risk stratification; RivaroxabaneducationRisk stratificationAgedRivaroxabanbusiness.industryManagement trial030229 sport sciences3126 Surgery anesthesiology intensive care radiologymedicine.diseaseInterim analysisOUTPATIENT TREATMENTConfidence intervalhyytymisenestohoitoClinical trialTHROMBOSIS3121 General medicine internal medicine and other clinical medicinelääkehoitosydän- ja verisuonitauditveritulppabusinessPulmonary EmbolismFactor Xa InhibitorsEuropean heart journal
researchProduct

The temporal association between executive function and life-space mobility in old age

2018

Background Life-space mobility, an indicator of community mobility, describes person’s movements in terms of the distance from home, the frequency of movement, and the need of assistance for movement. Executive function (EF) is a higher-order cognitive function that supervises motor control and plays a key role in a person’s ability to function independently. Cognitive impairment often co-occurs with restricted life-space mobility; however, the direction of the longitudinal associations between EF and life-space mobility is unclear. The aim of this study was to investigate the temporal associations between EF and life-space mobility among community-dwelling older people. Methods One hundred…

Malekognitiiviset taidotAgingTrail Making TestPoison controlliikuntaOccupational safety and health03 medical and health sciencesDisability EvaluationExecutive Function0302 clinical medicinePredictive Value of TestsInjury preventionActivities of Daily Livingmotor controlMedicineHumansCognitive Dysfunction030212 general & internal medicineCognitive declineMobility Limitation10. No inequalityGeriatric AssessmentAgedAged 80 and overSuccessful agingbusiness.industrycognitive agingHuman factors and ergonomicsCognitionsuccessful agingta3142ikääntyminenQuality of LifeFemaleIndependent LivingliikkuminenGeriatrics and Gerontologybusiness030217 neurology & neurosurgeryDemographyFollow-Up Studies
researchProduct

Muscle fiber-type distribution predicts weight gain and unfavorable left ventricular geometry: a 19 year follow-up study

2006

Abstract Background Skeletal muscle consists of type-I (slow-twitch) and type-II (fast-twitch) fibers, with proportions highly variable between individuals and mostly determined by genetic factors. Cross-sectional studies have associated low percentage of type-I fibers (type-I%) with many cardiovascular risk factors. Methods We investigated whether baseline type-I% predicts left ventricular (LV) structure and function at 19-year follow-up, and if so, which are the strongest mediating factors. At baseline in 1984 muscle fiber-type distribution (by actomyosin ATPase staining) was studied in 63 healthy men (aged 32–58 years). The follow-up in 2003 included echocardiography, measurement of obes…

Malelcsh:Diseases of the circulatory (Cardiovascular) systemTime Factors030204 cardiovascular system & hematologyDoppler echocardiographyWeight GainBody fat percentageCohort StudiesVentricular Dysfunction Left0302 clinical medicineReference Valuesmedicine.diagnostic_testIncidenceBiopsy NeedleMiddle AgedEchocardiography Dopplermedicine.anatomical_structureMuscle Fibers Slow-TwitchCardiovascular DiseasesMuscle Fibers Fast-TwitchCardiologyRegression Analysismedicine.symptomCardiology and Cardiovascular MedicineResearch ArticleAdultmedicine.medical_specialtyWaistRisk AssessmentSensitivity and Specificity03 medical and health sciencesAge DistributionPredictive Value of TestsInternal medicineHeart ratemedicineHumansObesityMuscle SkeletalAngiologyAgedProbabilityRetrospective Studiesbusiness.industrySkeletal muscle030229 sport sciencesMyocardial ContractionBlood pressurelcsh:RC666-701businessWeight gainFollow-Up StudiesBMC Cardiovascular Disorders
researchProduct

Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline

2020

Abstract Background Left ventricular ejection fraction (LVEF) trajectories and functional recovery with current heart failure (HF) management is increasingly recognized. Type 2 diabetes mellitus (T2D) leads to a worse prognosis in HF patients. However, it is unknown whether T2D interferes with LVEF trajectories. The aim of this study was to prospectively assess very long-term (up to 15 years) LVEF trajectories in patients with and without T2D and underlying HF. Methods Ambulatory patients admitted to a multidisciplinary HF clinic were prospectively evaluated by scheduled two-dimensional echocardiography at baseline, 1 year, and then every 2 years afterwards, up to 15 years. Statistical anal…

Malelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyEjection fractionTime FactorsEtiologyDiabetic CardiomyopathiesEndocrinology Diabetes and MetabolismHeart failureType 2 diabetesVentricular Function LeftVentricular Dysfunction LeftDiabetes mellitusLong-termRisk FactorsInternal medicineDiabetes mellitusDiabetic cardiomyopathymedicineHumansProspective StudiesOriginal InvestigationAngiologyAgedHeart FailureEjection fractionbusiness.industryFollow-upType 2 Diabetes MellitusStroke VolumeMiddle Agedmedicine.diseaseProgression-Free SurvivalDiabetes Mellitus Type 2lcsh:RC666-701Heart failureAmbulatoryDisease ProgressionFemaleCardiology and Cardiovascular Medicinebusiness
researchProduct

In utero Δ9-tetrahydrocannabinol exposure confers vulnerability towards cognitive impairments and alcohol drinking in the adolescent offspring: Is th…

2020

Background:Cannabinoid consumption during pregnancy has been increasing on the wave of the broad-based legalisation of cannabis in Western countries, raising concern about the putative detrimental outcomes on foetal neurodevelopment. Indeed, since the endocannabinoid system regulates synaptic plasticity, emotional and cognitive processes from early stages of life interfering with it and other excitability endogenous modulators, such as neuropeptide Y (NPY), might contribute to the occurrence of a vulnerable phenotype later in life.Aims:This research investigated whether in utero exposure to Δ9-tetrahydrocannabinol (THC) may induce deficits in emotional/cognitive processes and alcohol vulner…

Malelimbic memoryAlcohol Drinkingmedicine.medical_treatmentVulnerabilityPhysiologyAlcoholMotor ActivityConflict Psychological03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMemoryPregnancymental disordersMedicineAnimalsPharmacology (medical)Cognitive DysfunctionNeuropeptide YPrenatal THCDronabinolRats Wistarinstrumental learningPharmacologyPregnancybiologyBehavior Animalbusiness.industryBrainCognitionalcohol vulnerabilitybiology.organism_classificationmedicine.diseaseNeuropeptide Y receptor030227 psychiatryRatsPsychiatry and Mental healthchemistryIn uteroPrenatal Exposure Delayed EffectsSettore BIO/14 - FarmacologiaadolescenceFemaleCannabisCannabinoidbusiness030217 neurology & neurosurgeryJournal of psychopharmacology (Oxford, England)
researchProduct

Albumin replacement in patients with severe sepsis or septic shock.

2014

BACKGROUND: Although previous studies have suggested the potential advantages of albumin administration in patients with severe sepsis, its efficacy has not been fully established. METHODS: In this multicenter, open-label trial, we randomly assigned 1818 patients with severe sepsis, in 100 intensive care units (ICUs), to receive either 20% albumin and crystalloid solution or crystalloid solution alone. In the albumin group, the target serum albumin concentration was 30 g per liter or more until discharge from the ICU or 28 days after randomization. The primary outcome was death from any cause at 28 days. Secondary outcomes were death from any cause at 90 days, the number of patients with or…

Malemedicine.medical_specialtyALBUMIN SEPSIS SEVERE SEPSIS SEPTIC SHOCKSepsiSerum albuminSettore MED/41 - AnestesiologiaAged; Albumins; Female; Humans; Isotonic Solutions; Male; Middle Aged; Rehydration Solutions; Sepsis; Serum Albumin; Shock Septic; Survival Rate; Treatment OutcomeSepsisIntensive careAlbuminsSepsismedicineHumansalbumin replacementSurvival rateSerum AlbuminIsotonic SolutionAgedAged; Albumins; Female; Humans; Isotonic Solutions; Male; Middle Aged; Rehydration Solutions; Sepsis; Serum Albumin; Shock Septic; Survival Rate; Treatment Outcome; Medicine (all)SEPSISbiologybusiness.industrySeptic shockRehydration SolutionSepticMedicine (all)AlbuminSEPTIC SHOCKOrgan dysfunctionAlbuminShockGeneral MedicineMiddle Agedmedicine.diseaseShock SepticSurgerySurvival RateTreatment OutcomeAnesthesiaRelative riskRehydration Solutionsbiology.proteinFemalemedicine.symptomIsotonic SolutionsbusinessHuman
researchProduct

Influence of Comorbid Conditions on One-Year Outcomes in Non–ST-Segment Elevation Acute Coronary Syndrome

2011

To investigate comorbid conditions with prognostic influence in non-ST-segment elevation acute coronary syndrome (NSTEACS).The study group consisted of a derivation cohort of 1017 patients (admitted from October 1, 2002, through October 1, 2008) and an external validation cohort of 652 patients (admitted from February 1, 2006, through September 30, 2009). Comorbid conditions, including risk factors and components of the Charlson comorbidity index (ChCI) and coronary artery disease-specific index, were recorded. The main outcome was one-year mortality.During follow-up, 103 patients died. After adjusting for variables associated with NSTEACS characteristics (base model), 5 comorbid conditions…

Malemedicine.medical_specialtyAcute coronary syndromeMyocardial InfarctionComorbidityRisk AssessmentCoronary artery diseaseVentricular Dysfunction LeftInternal medicinemedicineHumansMyocardial infarctionProspective StudiesAcute Coronary SyndromeAgedAged 80 and overbusiness.industryST elevationMortality rateHazard ratioStroke VolumeGeneral MedicineMiddle Agedmedicine.diseasePrognosisComorbiditySurvival AnalysisConfidence intervalSurgeryMultivariate AnalysisCardiologyOriginal ArticleFemalebusiness
researchProduct